Ro-23-9358

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRo-23-9358
Drug Alias NameRo-23-9358
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSecretory phospholipase A2 inhibitors
TargetsSecretory phospholipase A2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A